Ionis Pharmaceuticals Inc (NASDAQ:IONS)

50.05
Delayed Data
As of Feb 16
 +0.27 / +0.54%
Today’s Change
37.26
Today|||52-Week Range
65.51
-0.50%
Year-to-Date
Biogen Halts Tysabri Development in Stroke as Study Fails
Feb 08 / Zacks.com - Paid Partner Content